Hermine L. Brunner, MD., MSc, MBA is a clinical and translational scientist. She leads the Division of Rheumatology at Cincinnati Children’s Hospital. Her research at Cincinnati Children’s is focused on the development of clinical trial endpoints, surrogate measures and biomarkers as they pertain to pediatric rheumatic diseases.
She serves as the scientific director of the Pediatric Rheumatology Collaborative Study Group, where she works alongside researchers at more than 80 academic centers across the U.S. and Canada. As part of this network I design and conduct clinical trials to test new medications for the treatment of children with rheumatic diseases.